Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Depreciation & Amortization
Abbott Laboratories
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
$3.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Depreciation & Amortization
$2.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
$1.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Depreciation & Amortization
$144.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
$1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
$454.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
21%
|
See Also
What is Abbott Laboratories's Depreciation & Amortization?
Depreciation & Amortization
3.2B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Depreciation & Amortization amounts to 3.2B USD.
What is Abbott Laboratories's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
7%
Over the last year, the Depreciation & Amortization growth was 0%. The average annual Depreciation & Amortization growth rates for Abbott Laboratories have been -2% over the past three years , and 7% over the past ten years .